Schizophrenia and Schizoaffective Disorder Clinical Trial
Official title:
A Multicenter, Open-Label, Parallel-Group, Randomized, Flexible Dose Study To Evaluate the Safety and Tolerability of Switching From Existing Atypical Antipsychotics to Bifeprunox in Subjects With Schizophrenia or Schizoaffective Disorder
The study will evaluate the safety and tolerability of switching subjects with schizophrenia or schizoaffective disorder from their existing antipsychotic medication to Bifeprunox.
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00292409 -
A Study of Aripiprazole in Patients With Schizophrenia in General Psychiatric Practices
|
Phase 3 | |
Active, not recruiting |
NCT01804920 -
D-Serine Treatment For Tardive Dyskinesia
|
N/A |